Showing results (191-200 of 465) with videos related to

Sort By:
Pageof 47
Manual Therapy|October 17, 2016
Agreement between a physiotherapist and an orthopaedic surgeon regarding management and prescription of corticosteroid injection for patients with shoulder painDarryn Marks, Tracy Comans, Michael Thomas, et al.
Rheumatology Advances in Practice|February 16, 2023
Evaluating the efficacy of upadacitinib in patients with moderate rheumatoid arthritis: a post-hoc analysis of the SELECT phase 3 trialsPhilip G Conaghan, Karel Pavelka, Song-Chou Hsieh, et al.
Annals of the Rheumatic Diseases|February 18, 2016
Does flare trial design affect the effect size of non-steroidal anti-inflammatory drugs in symptomatic osteoarthritis? A systematic review and meta-analysisToby O Smith, Kun Zou, Natasya Abdullah, et al.
Annals of the Rheumatic Diseases|December 17, 2015
Osteoarthritic bone marrow lesions almost exclusively colocate with denuded cartilage: a 3D study using data from the Osteoarthritis InitiativeMichael A Bowes, Stewart Wd McLure, Christopher Bh Wolstenholme, et al.
Radiology|October 20, 2020
Intra-articular Corticosteroid Injections for the Treatment of Hip and Knee Osteoarthritis-related Pain: Considerations and Controversies with a Focus on Imaging-Radiology Scientific Expert PanelAli Guermazi, Tuhina Neogi, Jeffrey N Katz, et al.
Plos One|March 19, 2014
CTXA hip--an extension of classical DXA measurements using quantitative CTChristopher E Cann, Judith E Adams, J Keenan Brown, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 24, 2014
Development and validation of modified disease activity scores in rheumatoid arthritis: superior correlation with magnetic resonance imaging-detected synovitis and radiographic progressionJoshua F Baker, Philip G Conaghan, Josef S Smolen, et al.
Rheumatology (Oxford, England)|April 25, 2023
Enthesitis in patients with psoriatic arthritis treated with secukinumab or adalimumab: a post hoc analysis of the EXCEED studyGurjit S Kaeley, Georg Schett, Philip G Conaghan, et al.
Clinical and Experimental Rheumatology|August 28, 2018
Secukinumab provides rapid and persistent relief in pain and fatigue symptoms in patients with ankylosing spondylitis irrespective of baseline C-reactive protein levels or prior tumour necrosis factor inhibitor therapy: 2-year data from the MEASURE 2 studyAtul Deodhar, Philip G Conaghan, Tore K Kvien, et al.
Plos One|May 10, 2024
Long-term health conditions and UK labour market outcomes during the COVID-19 pandemicEdward J D Webb, Philip G Conaghan, Max Henderson, et al.
Pageof 47